{"brief_title": "Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria", "brief_summary": "Study of the efficacy and safety of aliskiren when added to losartan and optimal antihypertensive therapy in patients with hypertension, type 2 diabetes, and kidney disorders to monitor improvement in any of these conditions.", "condition": ["Diabetic Nephropathy"], "intervention_type": ["Drug"], "intervention_name": ["aliskiren"], "criteria": "Inclusion Criteria: - Hypertension - Elevated urinary protein levels - Confirmed type 2 diabetes Exclusion Criteria: - Certain diseases - Uncontrolled diabetes - Type 1 diabetes", "gender": "All", "minimum_age": "18 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "keyword": "losartan", "mesh_term": ["Hypertension", "Kidney Diseases", "Proteinuria", "Diabetic Nephropathies", "Antihypertensive Agents", "Losartan"], "id": "NCT00097955"}